Sopharma’s top line further deteriorates in Q4’2014 due to Ukraine
Sopharma Q1’15 preliminary results show further deterioration caused also by the January FX turbulence in Russia
© 1991 - 2026 ELANA | ELANA Trading Privacy policy Change Cookie Preferences